PNC Financial Services Group Inc. Decreases Position in Humana Inc. $HUM

PNC Financial Services Group Inc. decreased its position in Humana Inc. (NYSE:HUM) by 2.2% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 64,665 shares of the insurance provider’s stock after selling 1,460 shares during the period. PNC Financial Services Group Inc.’s holdings in Humana were worth $11,212,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the company. Aberdeen Group plc raised its position in Humana by 18.1% during the fourth quarter. Aberdeen Group plc now owns 283,778 shares of the insurance provider’s stock worth $72,684,000 after acquiring an additional 43,442 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. grew its position in shares of Humana by 4.1% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock valued at $66,207,000 after purchasing an additional 9,960 shares during the last quarter. Ninety One UK Ltd grew its position in shares of Humana by 57.2% in the fourth quarter. Ninety One UK Ltd now owns 112,501 shares of the insurance provider’s stock valued at $28,815,000 after purchasing an additional 40,958 shares during the last quarter. Sustainable Insight Capital Management LLC increased its stake in shares of Humana by 23.7% during the 4th quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock worth $6,341,000 after purchasing an additional 4,740 shares in the last quarter. Finally, Swedbank AB increased its stake in shares of Humana by 6.2% during the 4th quarter. Swedbank AB now owns 111,803 shares of the insurance provider’s stock worth $28,636,000 after purchasing an additional 6,534 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

HUM has been the topic of a number of recent research reports. Guggenheim upped their target price on Humana from $252.00 to $269.00 and gave the company a “buy” rating in a research note on Thursday, April 30th. Weiss Ratings raised Humana from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 29th. Zacks Research raised Humana from a “hold” rating to a “strong-buy” rating in a report on Monday, July 13th. UBS Group restated a “neutral” rating on shares of Humana in a research report on Monday, June 15th. Finally, Jefferies Financial Group raised Humana from a “buy” rating to a “buy” rating in a research note on Wednesday, May 20th. Two analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating, fifteen have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, Humana has a consensus rating of “Hold” and an average price target of $327.17.

Humana Stock Performance

Shares of HUM opened at $388.56 on Friday. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $428.88. The company’s 50 day simple moving average is $364.10 and its 200 day simple moving average is $265.01. The company has a market capitalization of $46.65 billion, a price-to-earnings ratio of 41.56, a PEG ratio of 2.12 and a beta of 0.71. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, topping the consensus estimate of $9.97 by $0.34. The firm had revenue of $39.65 billion during the quarter, compared to analysts’ expectations of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. Humana’s revenue for the quarter was up 23.5% on a year-over-year basis. During the same period in the previous year, the company earned $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. On average, sell-side analysts predict that Humana Inc. will post 9.46 EPS for the current year.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.